450 related articles for article (PubMed ID: 23069763)
1. Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.
Schmidt W; Schäfer F; Striggow V; Fröhlich K; Striggow F
Neuroscience; 2012 Dec; 227():313-26. PubMed ID: 23069763
[TBL] [Abstract][Full Text] [Related]
2. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Kokona D; Thermos K
Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
[TBL] [Abstract][Full Text] [Related]
3. Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus.
Zheng L; Wu X; Dong X; Ding X; Song C
Alcohol Clin Exp Res; 2015 Oct; 39(10):1908-16. PubMed ID: 26343919
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage.
Shouman B; Fontaine RH; Baud O; Schwendimann L; Keller M; Spedding M; Lelièvre V; Gressens P
Br J Pharmacol; 2006 Jun; 148(4):442-51. PubMed ID: 16682966
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties.
Mauler F; Mittendorf J; Horváth E; De Vry J
J Pharmacol Exp Ther; 2002 Jul; 302(1):359-68. PubMed ID: 12065738
[TBL] [Abstract][Full Text] [Related]
6. Ligand activation of cannabinoid receptors attenuates hypertrophy of neonatal rat cardiomyocytes.
Lu Y; Akinwumi BC; Shao Z; Anderson HD
J Cardiovasc Pharmacol; 2014 Nov; 64(5):420-30. PubMed ID: 24979612
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid CB1 receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro.
Iuvone T; Esposito G; De Filippis D; Bisogno T; Petrosino S; Scuderi C; Di Marzo V; Steardo L;
J Mol Med (Berl); 2007 Dec; 85(12):1379-92. PubMed ID: 17639288
[TBL] [Abstract][Full Text] [Related]
8. Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain.
Ashton JC; Rahman RM; Nair SM; Sutherland BA; Glass M; Appleton I
Neurosci Lett; 2007 Jan; 412(2):114-7. PubMed ID: 17123706
[TBL] [Abstract][Full Text] [Related]
9. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
10. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors.
Song S; Kong X; Borlongan C; Sava V; Sanchez-Ramos J
Cannabis Cannabinoid Res; 2021; 6(1):48-57. PubMed ID: 33614952
[No Abstract] [Full Text] [Related]
12. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system.
Wang Q; Peng Y; Chen S; Gou X; Hu B; Du J; Lu Y; Xiong L
Stroke; 2009 Jun; 40(6):2157-64. PubMed ID: 19372445
[TBL] [Abstract][Full Text] [Related]
13. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB
Navarro G; Borroto-Escuela D; Angelats E; Etayo Í; Reyes-Resina I; Pulido-Salgado M; Rodríguez-Pérez AI; Canela EI; Saura J; Lanciego JL; Labandeira-García JL; Saura CA; Fuxe K; Franco R
Brain Behav Immun; 2018 Jan; 67():139-151. PubMed ID: 28843453
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
Ashton JC; Wright JL; McPartland JM; Tyndall JD
Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
[TBL] [Abstract][Full Text] [Related]
15. Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial.
Firsching R; Piek J; Skalej M; Rohde V; Schmidt U; Striggow F;
J Neurol Surg A Cent Eur Neurosurg; 2012 Aug; 73(4):204-16. PubMed ID: 22696266
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.
García-Arencibia M; González S; de Lago E; Ramos JA; Mechoulam R; Fernández-Ruiz J
Brain Res; 2007 Feb; 1134(1):162-70. PubMed ID: 17196181
[TBL] [Abstract][Full Text] [Related]
17. Role of hypothalamic cannabinoid receptors in post-stroke depression in rats.
Wang S; Sun H; Liu S; Wang T; Guan J; Jia J
Brain Res Bull; 2016 Mar; 121():91-7. PubMed ID: 26778127
[TBL] [Abstract][Full Text] [Related]
18. Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement.
Spyridakos D; Papadogkonaki S; Dionysopoulou S; Mastrodimou N; Polioudaki H; Thermos K
Neurochem Int; 2021 Jan; 142():104907. PubMed ID: 33220388
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
20. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
